{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:46:49Z","timestamp":1785876409718,"version":"3.56.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA197964"],"award-info":[{"award-number":["R01CA197964"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1RO1CA123211"],"award-info":[{"award-number":["1RO1CA123211"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21CA198698"],"award-info":[{"award-number":["1R21CA198698"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001543","name":"The Children&apos;s Cancer Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008064","name":"Georgetown University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005954","name":"Children\u2019s Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.npep.2026.102638","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:13:15Z","timestamp":1781453595000},"page":"102638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neuropeptide Y in cancer metastasis and chemoresistance"],"prefix":"10.1016","volume":"118","author":[{"given":"Ewa","family":"Krawczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kitlinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2026.102638_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-5793(90)80069-U","article-title":"Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase","volume":"260","author":"Aakerlund","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.npep.2026.102638_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.627090","article-title":"Neuropeptide Y\/Y5 receptor pathway stimulates neuroblastoma cell motility through RhoA activation","volume":"8","author":"Abualsaud","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.npep.2026.102638_bb0015","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1038\/s41388-025-03493-y","article-title":"Targeted CRISPR approach reveals an essential role for neuropeptide Y receptor Y5 in Ewing sarcoma extrapulmonary metastasis","volume":"44","author":"Adnani","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.npep.2026.102638_bb0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.euo.2019.05.001","article-title":"Transcriptomic and clinical characterization of neuropeptide Y expression in localized and metastatic prostate cancer: identification of novel prostate cancer subtype with clinical implications","volume":"2","author":"Alshalalfa","year":"2019","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.npep.2026.102638_bb0025","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1158\/0008-5472.CAN-05-2744","article-title":"Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line","volume":"66","author":"Amlal","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.npep.2026.102638_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.838434","article-title":"Current insights into the role of neuropeptide Y in skin physiology and pathology","author":"Anderson","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.npep.2026.102638_bb0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1139\/cjpp-2014-0099","article-title":"The effect of neuropeptide Y on cell survival and neurotrophin expression in in-vitro models of Alzheimer\u2019s disease","volume":"92","author":"Angelucci","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.npep.2026.102638_bb0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1113\/EP092325","article-title":"Circulating neuropeptide Y dynamics and performance during exercise in heart failure patients with contemporary medical and device therapy","volume":"110","author":"Ayagama","year":"2025","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.npep.2026.102638_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2023.102388","article-title":"Cross talk about the role of neuropeptide Y in CNS disorders and diseases","author":"Bale","year":"2023","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2026.102638_bb0050","doi-asserted-by":"crossref","first-page":"26762","DOI":"10.1074\/jbc.270.45.26762","article-title":"Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY*","volume":"270","author":"Bard","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2026.102638_bb0055","article-title":"Crosstalk of NPY and TGF\u03b2 orchestrates the signaling to facilitate perineural invasion of oral squamous cell carcinoma","author":"Bi","year":"2025","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.npep.2026.102638_bb0060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0196-9781(01)00346-1","article-title":"Limited signal transduction repertoire of human Y(5) neuropeptide Y receptors expressed in HEC-1B cells","volume":"22","author":"Bischoff","year":"2001","journal-title":"Peptides (N.Y.)"},{"key":"10.1016\/j.npep.2026.102638_bb0065","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1021\/acs.bioconjchem.3c00313","article-title":"Development of radiopharmaceuticals for NPY receptor-5 (Y5) nuclear imaging in tumors by synthesis of specific agonists and investigation of their binding mode","volume":"34","author":"Bodin","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.npep.2026.102638_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2026.02.003","article-title":"Obesity, type 2 diabetes and cancers of the digestive system","volume":"121","author":"Cernea","year":"2026","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.npep.2026.102638_bb0075","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/s41416-022-01916-1","article-title":"Neuropeptide Y, a paracrine factor secreted by cancer cells, is an independent regulator of angiogenesis in colon cancer","volume":"127","author":"Chakroborty","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.npep.2026.102638_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adq4416","article-title":"Targeting the NPY\/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis","volume":"11","author":"Chambers","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.npep.2026.102638_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-020-0612-8","article-title":"Design, synthesis, and biological evaluation of a multifunctional neuropeptide-Y conjugate for selective nuclear delivery of radiolanthanides","volume":"10","author":"Chastel","year":"2020","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.npep.2026.102638_bb0090","doi-asserted-by":"crossref","DOI":"10.1007\/s00223-025-01443-0","article-title":"Osteocyte neuropeptide Y aggravates bone loss in OVX mice by inhibiting preosteoclast proliferation and PDGF-BB-induced type H vessel formation through PI3K\/Akt signaling pathway","volume":"116","author":"Chen","year":"2025","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.npep.2026.102638_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.580378","article-title":"Neuropeptide Y is an immunomodulatory factor: direct and indirect","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.npep.2026.102638_bb0100","doi-asserted-by":"crossref","DOI":"10.1007\/s12672-025-03950-w","article-title":"Research progress on chronic stress stimulation and gastric cancer metastasis","author":"Chen","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.npep.2026.102638_bb0105","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1158\/1078-0432.CCR-18-2912","article-title":"Depression-induced neuropeptide y secretion promotes prostate cancer growth by recruiting myeloid cells","volume":"25","author":"Cheng","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.npep.2026.102638_bb0110","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1038\/onc.2014.253","article-title":"Neuropeptide y receptor Y5 as an inducible pro-survival factor in neuroblastoma: Implications for tumor chemoresistance","volume":"34","author":"Czarnecka","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.npep.2026.102638_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.npep.2018.11.008","article-title":"Neuropeptide Y receptor interactions regulate its mitogenic activity","volume":"73","author":"Czarnecka","year":"2019","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2026.102638_bb0120","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1172\/JCI131919","article-title":"Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer","volume":"130","author":"Dietrich","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.npep.2026.102638_bb0125","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/pros.24081","article-title":"Neuropeptide Y nerve paracrine regulation of prostate cancer oncogenesis and therapy resistance","volume":"81","author":"Ding","year":"2021","journal-title":"Prostate"},{"key":"10.1016\/j.npep.2026.102638_bb0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/protein\/10.2.109","article-title":"Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites","volume":"10","author":"Du","year":"1997","journal-title":"Protein Eng"},{"key":"10.1016\/j.npep.2026.102638_bb0135","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1073\/pnas.1135965100","article-title":"Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing","volume":"100","author":"Ekstrand","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.npep.2026.102638_bb0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cmet.2006.08.002","article-title":"Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults","volume":"4","author":"Erondu","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.npep.2026.102638_bb0145","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/oby.2007.620","article-title":"Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss","volume":"15","author":"Erondu","year":"2007","journal-title":"Obesity"},{"key":"10.1016\/j.npep.2026.102638_bb0150","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1016\/j.ajpath.2016.07.019","article-title":"Neuropeptide Y as a biomarker and therapeutic target for neuroblastoma","volume":"186","author":"Galli","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.npep.2026.102638_bb0155","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.bcp.2007.08.017","article-title":"Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties","volume":"74","author":"Gehlert","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.npep.2026.102638_bb0160","series-title":"The NPY Family of Peptides in Immune Disorders, Inflammation, Angiogenesis, and Cancer","article-title":"NPY processing in neuronal and non-neuronal tissues by proconvertases","author":"Grouzmann","year":"2005"},{"key":"10.1016\/j.npep.2026.102638_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.12.049","article-title":"Hallmarks of cancer-then and now, and beyond","author":"Hanahan","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.npep.2026.102638_bb0170","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4161\/cc.7.2.5229","article-title":"A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature","volume":"7","author":"Hancock","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.npep.2026.102638_bb0175","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/ijms27020686","article-title":"The impact of chronic stress on treatment outcomes of cancer patients with divergent survival rates: a systematic review","volume":"27","author":"Herbetko","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.npep.2026.102638_bb0180","doi-asserted-by":"crossref","DOI":"10.1007\/s10571-011-9793-z","article-title":"NPY and stress 30 years later: the peripheral view","author":"Hirsch","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.npep.2026.102638_bb0185","first-page":"6462","article-title":"Resistance to chemotherapy mediated by TrkB in neuroblastomas","volume":"62","author":"Ho","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.npep.2026.102638_bb0190","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.18632\/oncotarget.3345","article-title":"High neuropeptide Y release associates with Ewing sarcoma bone dissemination-in vivo model of site-specific metastases","volume":"6","author":"Hong","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.npep.2026.102638_bb0195","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.eururo.2015.10.053","article-title":"The proteome of primary prostate cancer","volume":"69","author":"Iglesias-Gato","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.npep.2026.102638_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102176","article-title":"Stress and high fat diet reconfigure the active translatome of CeA-NPY neurons","volume":"98","author":"Ip","year":"2025","journal-title":"Mol. Metab."},{"key":"10.1016\/j.npep.2026.102638_bb0205","first-page":"14","article-title":"Neuropeptide Y \u2013 its role in human performance and extreme environments","author":"Kienast","year":"2019","journal-title":"REACH"},{"key":"10.1016\/j.npep.2026.102638_bb0210","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1124\/mol.114.095356","article-title":"A G protein\u2013coupled receptor dimer imaging assay reveals selectively modified pharmacology of neuropeptide Y Y1\/Y5 receptor heterodimers","volume":"87","author":"Kilpatrick","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.npep.2026.102638_bb0215","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1245\/s10434-011-1573-y","article-title":"Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations","volume":"18","author":"Kim","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.npep.2026.102638_bb0220","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1158\/0008-5472.CAN-04-2192","article-title":"Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors","volume":"65","author":"Kitlinska","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.npep.2026.102638_bb0225","series-title":"The NPY Family of Peptides in Immune Disorders, Inflammation, Angiogenesis and Cancer","article-title":"NPY as a pleiotropic growth factor","author":"Kitlinska","year":"2005"},{"key":"10.1016\/j.npep.2026.102638_bb0230","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.3390\/cancers15133314","article-title":"Preclinical models of neuroblastoma - current status and perspectives","volume":"15","author":"Krawczyk","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.npep.2026.102638_bb0235","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nm1611","article-title":"Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome","volume":"13","author":"Kuo","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.npep.2026.102638_bb0240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0196-9781(02)00281-4","article-title":"Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice","volume":"24","author":"Lee","year":"2003","journal-title":"Peptides (N.Y.)"},{"key":"10.1016\/j.npep.2026.102638_bb0245","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI16929","article-title":"Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles","volume":"111","author":"Lee","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.npep.2026.102638_bb0250","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejcb.2018.04.003","article-title":"Neuropeptide Y mitigates ER stress-induced neuronal cell death by activating the PI3K-XBP1 pathway","volume":"97","author":"Lee","year":"2018","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.npep.2026.102638_bb0255","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12265-011-9271-5","article-title":"Of mice and men: Neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability","volume":"4","author":"Li","year":"2011","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.npep.2026.102638_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.705499","article-title":"Update on the role of neuropeptide Y and other related factors in breast cancer and osteoporosis","author":"Lin","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.npep.2026.102638_bb0265","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3892\/ol.2014.2721","article-title":"NPY1R is a novel peripheral blood marker predictive of metastasis and prognosis in breast cancer patients","volume":"9","author":"Liu","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.npep.2026.102638_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.798221","article-title":"The novel methylation biomarker NPY5R sensitizes breast cancer cells to chemotherapy","volume":"9","author":"Liu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.npep.2026.102638_bb0275","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.molmet.2017.03.013","article-title":"Insulin controls food intake and energy balance via NPY neurons","volume":"6","author":"Loh","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.npep.2026.102638_bb0280","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-026-02143-8","article-title":"A liquid biopsy-based multi-methylation marker panel for minimally invasive gastric cancer screening","author":"Long","year":"2026","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.npep.2026.102638_bb0285","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1038\/onc.2010.301","article-title":"Neuropeptide y and its Y2 receptor: potential targets in neuroblastoma therapy","volume":"29","author":"Lu","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.npep.2026.102638_bb0290","doi-asserted-by":"crossref","first-page":"27494","DOI":"10.1074\/jbc.M111.224089","article-title":"Dipeptidyl peptidases as survival factors in ewing sarcoma family of tumors: implications for tumor biology and therapy","volume":"286","author":"Lu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2026.102638_bb0295","article-title":"Hypoxia-activated neuropeptide Y\/Y5 receptor\/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma","volume":"13","author":"Lu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.npep.2026.102638_bb0300","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12032-016-0785-1","article-title":"Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma","volume":"33","author":"Lv","year":"2016","journal-title":"Med. Oncol."},{"key":"10.1016\/j.npep.2026.102638_bb0305","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-024-01032-5","article-title":"The multifactorial effect of obesity on the effectiveness and outcomes of cancer therapies","author":"Lysaght","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.npep.2026.102638_bb0310","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(02)01889-7","article-title":"Pharmacology of neuropeptide Y receptor antagonists focus on cardiovascular functions","volume":"447","author":"Malmstr\u00f6m","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2026.102638_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055207","article-title":"Characterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y","volume":"8","author":"Massoner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.npep.2026.102638_bb0320","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.peptides.2013.07.029","article-title":"Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis","volume":"48","author":"Medeiros","year":"2013","journal-title":"Peptides (N.Y.)"},{"key":"10.1016\/j.npep.2026.102638_bb0325","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.26350","article-title":"Neuropeptide y stimulates proliferation and migration in the 4T1 breast cancer cell line","volume":"131","author":"Medeiros","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.npep.2026.102638_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101645","article-title":"Expression of hypoxia inducible factor-dependent neuropeptide Y receptors Y1 and Y5 sensitizes hypoxic cells to NPY stimulation","volume":"298","author":"Medeiros","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2026.102638_bb0335","series-title":"The NPY Family of Peptides in Immune Disorders, Inflammation, Angiogenesis and Cancer","article-title":"Dipeptidyl-peptidase IV and aminopeptidase P: molecular switches of NPY\/PYY receptor affinities","author":"Mentlein","year":"2005"},{"key":"10.1016\/j.npep.2026.102638_bb0340","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-018-0485-0","article-title":"The neuropeptide genes SST, TAC1, HCRT, NPY, and GAL are powerful epigenetic biomarkers in head and neck cancer: A site-specific analysis","volume":"10","author":"Misawa","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.npep.2026.102638_bb0345","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1096\/fj.05-4770fje","article-title":"Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors","volume":"20","author":"Movafagh","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.npep.2026.102638_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218825","article-title":"Paradoxical relationship between body mass index and bone mineral density in patients with non\u2013small cell lung cancer with brain metastasis","volume":"14","author":"Nam","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.npep.2026.102638_bb0355","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1097\/MS9.0000000000003304","article-title":"Stress, neutrophils, and immunity: a dynamic interplay","volume":"87","author":"Obeagu","year":"2025","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.npep.2026.102638_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112059","article-title":"Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1","volume":"42","author":"Ortiz","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.npep.2026.102638_bb0365","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-08816-2","article-title":"The detection of specific hypermethylated WIF1 and NPY genes in circulating DNA by crystal digital PCR\u2122 is a powerful new tool for colorectal cancer diagnosis and screening","volume":"21","author":"Overs","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.npep.2026.102638_bb0370","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-10993-1","article-title":"Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling","volume":"23","author":"Pascetta","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.npep.2026.102638_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2013.00005","article-title":"Neuropeptide y receptors: how to get subtype selectivity","volume":"4","author":"Pedragosa-Badia","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.npep.2026.102638_bb0380","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1073\/pnas.030533197","article-title":"Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors","volume":"97","author":"Pellieux","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.npep.2026.102638_bb0385","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1139\/y02-166","article-title":"Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the \u03b2-adrenergic system","author":"Pons","year":"2003","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.npep.2026.102638_bb0390","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1139\/Y08-054","article-title":"Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth","volume":"86","author":"Pons","year":"2008","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.npep.2026.102638_bb0395","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.ymthe.2021.10.005","article-title":"Neuropeptide Y attenuates cardiac remodeling and deterioration of function following myocardial infarction","volume":"30","author":"Qin","year":"2022","journal-title":"Mol. Therapy"},{"key":"10.1016\/j.npep.2026.102638_bb0400","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-022-07543-6","article-title":"Molecular relation between biological stress and carcinogenesis","author":"Rakoczy","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.npep.2026.102638_bb0405","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1055-9965.EPI-05-0752","article-title":"Aberrant neuropeptide Y and macrophage inhibitory cytokine-1 expression are early events in prostate cancer development and are associated with poor prognosis","volume":"15","author":"Rasiah","year":"2006","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.npep.2026.102638_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14184459","article-title":"NPY gene methylation in circulating tumor DNA as an early biomarker for treatment effect in metastatic colorectal cancer","volume":"14","author":"Raunkilde","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.npep.2026.102638_bb0415","series-title":"Annals of the New York Academy of Sciences","first-page":"133","article-title":"Angiogenesis in neuroblastoma","author":"Ribatti","year":"2004"},{"key":"10.1016\/j.npep.2026.102638_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27062731","article-title":"Targeting neuropeptide Y\/DPP4 signalling suppresses Ewing Sarcoma survival and improves monocyte viability","volume":"27","author":"Rumney","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.npep.2026.102638_bb0425","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/452524","article-title":"Diet-induced obesity in mice overexpressing neuropeptide y in noradrenergic neurons","volume":"2012","author":"Ruohonen","year":"2012","journal-title":"Int. J. Pept."},{"key":"10.1016\/j.npep.2026.102638_bb0430","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/en.2005-0925","article-title":"Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells","volume":"147","author":"Ruscica","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.npep.2026.102638_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2006.08.045","article-title":"Role of neuropeptide Y and its receptors in the progression of endocrine-related cancer","author":"Ruscica","year":"2007","journal-title":"Peptides (N.Y.)"},{"key":"10.1016\/j.npep.2026.102638_bb0440","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2012.101","article-title":"Neuropeptide Y and posttraumatic stress disorder","author":"Sah","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.npep.2026.102638_bb0445","article-title":"Neuropeptide Y peptide family and cancer: antitumor therapeutic strategies","author":"S\u00e1nchez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.npep.2026.102638_bb0450","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1158\/1541-7786.MCR-09-0301","article-title":"Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line","volume":"8","author":"Sheriff","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.npep.2026.102638_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.710899","article-title":"Investigation of neural microenvironment in prostate cancer in context of neural density, perineural invasion, and neuroendocrine profile of tumors","volume":"11","author":"Sigorski","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.npep.2026.102638_bb0460","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1007\/s00432-022-04540-x","article-title":"Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread","volume":"149","author":"Sigorski","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.npep.2026.102638_bb0465","doi-asserted-by":"crossref","DOI":"10.1007\/s10555-024-10237-z","article-title":"Neuropeptide Y in cancer\u2014biological functions and potential clinical implications","volume":"44","author":"Sigorski","year":"2025","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.npep.2026.102638_bb0470","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ccr.2006.04.004","article-title":"Expression profiling of EWS\/FLI identifies NKX2.2 as a critical target gene in Ewing\u2019s sarcoma","volume":"9","author":"Smith","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.npep.2026.102638_bb0475","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1582-4934.2009.00956.x","article-title":"Involvement of neuropeptide Y and its Y1 and Y5 receptors in maintaining self-renewal and proliferation of human embryonic stem cells","volume":"15","author":"Son","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.npep.2026.102638_bb0480","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1479164117704380","article-title":"Current views on neuropeptide y and diabetes-related atherosclerosis","volume":"14","author":"Sun","year":"2017","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.npep.2026.102638_bb0485","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-024-00756-y","article-title":"Mettl3-m6A-NPY axis governing neuron\u2013microglia interaction regulates sleep amount of mice","volume":"11","author":"Sun","year":"2025","journal-title":"Cell Discov."},{"key":"10.1016\/j.npep.2026.102638_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.01281","article-title":"The role of neuropeptide Y in cardiovascular health and disease","author":"Tan","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.npep.2026.102638_bb0495","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/ph19020322","article-title":"Targeting NPY5R\u2014a member of the NPY receptor family: pharmacological and transcriptomic mechanisms of the Euphorbia factor L2 against lung adenocarcinoma","volume":"19","author":"Tao","year":"2026","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.npep.2026.102638_bb0500","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.npep.2015.10.005","article-title":"Neuropeptide Y (NPY) in tumor growth and progression: lessons learned from pediatric oncology","volume":"55","author":"Tilan","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2026.102638_bb0505","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1096\/fj.12-213546","article-title":"Platelet neuropeptide y is critical for ischemic revascularization in mice","volume":"27","author":"Tilan","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.npep.2026.102638_bb0510","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.18632\/oncotarget.1604","article-title":"Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects","volume":"4","author":"Tilan","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.npep.2026.102638_bb0515","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/cncr.29090","article-title":"Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma - associations with tumor phenotype and survival","volume":"121","author":"Tilan","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.npep.2026.102638_bb0520","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/pros.23443","article-title":"Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response to abiraterone in castration resistant patients","volume":"78","author":"Tjon-Kon-Fat","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.npep.2026.102638_bb0525","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-60730-4","article-title":"Ghrelin-induced neuronal NPY promotes brain metastasis in lung cancer patients with low BMI","volume":"16","author":"Tyagi","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.npep.2026.102638_bb0530","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1021\/pr400547s","article-title":"Plasma low-molecular-weight proteome profiling identified neuropeptide-y as a prostate cancer biomarker polypeptide","volume":"12","author":"Ueda","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.npep.2026.102638_bb0535","series-title":"PP, PYY and NPY: Synthesis, Storage, Release and Degradation, Neuropeptide Y and Related Peptides","author":"von H\u00f6rsten","year":"2004"},{"key":"10.1016\/j.npep.2026.102638_bb0540","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2518418122","article-title":"The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche","volume":"122","author":"Wormser","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.npep.2026.102638_bb0545","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.neuron.2022.01.010","article-title":"Neuron-derived neuropeptide Y fine-tunes the splenic immune responses","volume":"110","author":"Yu","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.npep.2026.102638_bb0550","article-title":"Masticatory-driven piezoelectric hydrogels with electrical stimulation-triggered NPY condensate for mandibular bone regeneration","author":"Zhai","year":"2026","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.npep.2026.102638_bb0555","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1749-6632.1995.tb44683.x","article-title":"Neuropeptide Y: a novel sympathetic stress hormone and more","volume":"771","author":"Zukowska-Grojec","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417926000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417926000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:03:46Z","timestamp":1785873826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417926000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":111,"alternative-id":["S0143417926000545"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2026.102638","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropeptide Y in cancer metastasis and chemoresistance","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2026.102638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102638"}}